ETCTN A phase IB and randomized open-label phase II study of Berzosertib (M6620, VX-970) in combination with carboplatin/gemcitabine/pembrolizumab in patients with chemotherapy-naïve advanced non-small cell lung cancer of squamous cell histology Adult CIRB - Early Phase Emphasis Active Available to Open